<< Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion | GOP and industry groups quick to decry Senate health bill >>

Quest Diagnostics announces final results of its cash tender offer

Published on November 20, 2009 at 9:33 AM · No Comments

Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes"). Additional terms and conditions of the Tender Offer are set forth in the offer to purchase dated November 12, 2009 and the related letter of transmittal. The settlement date for the Tender Offer will be today, November 20, 2009.

SOURCE Quest Diagnostics Incorporated

8f3a2021-8f4d-4980-bad0-b25bdf01da5f|0|.0

Posted in:

Tags: Diagnostics

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patientsMerrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase ...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.